I. Yu. Razumova, A. S. Stoyukhina, L. Alharki, E. N. Korobov & E. D. Khachaturova. (2024) Cataract Surgery in Vogt — Koyanagi — Harada Syndrome (Clinical Case). Ophthalmology in Russia 21:1, pages 162-166.
Crossref
Hou-Ting Kuo, Chia-Yun Chen, Alan Y. Hsu, Yu-Hsun Wang, Chun-Ju Lin, Ning-Yi Hsia, Yi-Yu Tsai & James Cheng-Chung Wei. (2024) Association between immune checkpoint inhibitor medication and uveitis: a population-based cohort study utilizing TriNetX database. Frontiers in Immunology 14.
Crossref
Mohannad F. Tobaigy, Marwan A. Abouammoh, Abdulrahman F. AlBloushi, Amjad Ameen Saifaldein, Priscilla Gikandi, Abdullah N. Almousa, Carl P. HerbortJrJr & Ahmed Abu El‐Asrar. (2023) Prognostic value of pretreatment indocyanine green angiography in the acute uveitic phase of Vogt‐Koyanagi‐Harada disease. Acta Ophthalmologica.
Crossref
Ikuyo Sada, Yosuke Harada, Tomona Hiyama, Mina Mizukami, Takanobu Kan, Mikio Kawai & Yoshiaki Kiuchi. (2023) Uveitis associated with immune checkpoint inhibitors or BRAF/MEK inhibitors in patients with malignant melanoma. Melanoma Research 33:6, pages 539-546.
Crossref
Ahmed M. Abu El‐Asrar, Faisal A. Al Rashed, Abdulrahman F. AlBloushi, Mohannad F. Tobaigy, Priscilla W. Gikandi, Carl P. HerbortJr.Jr. & Ghislain Opdenakker. (2022)
Therapeutic window of opportunity in the acute uveitic phase of
Vogt–Koyanagi–Harada
disease: Prevention of late autoimmune complications by early intervention
. Acta Ophthalmologica 101:2.
Crossref
Faisal A. Almobarak, Ali H. Alharbi, Ibrahim Aljadaan & Hassan Aldhibi. (2022) Phacoemulsification after trabeculectomy in uveitis associated with Vogt-Koyanagi-Harada disease: intermediate-term visual outcome, IOP control and trabeculectomy survival. BMC Ophthalmology 22:1.
Crossref
Florence Chaudot, Pascal Sève, Antoine Rousseau, Alexandre Thibault Jacques Maria, Pierre Fournie, Pierre Lozach, Jeremy Keraen, Marion Servant, Romain Muller, Baptiste Gramont, Sara Touhami, Habeeb Mahmoud, Pierre-Antoine Quintart, Stéphane Dalle, Olivier Lambotte, Laurent Kodjikian & Yvan Jamilloux. (2022) Ocular Inflammation Induced by Immune Checkpoint Inhibitors. Journal of Clinical Medicine 11:17, pages 4993.
Crossref
Arwa Z. Alromaih, Abdullah I. Almater, Abdulrahman F. Albloushi, Norah F. Alkheraiji & Ahmed M. Abu El-Asrar. (2022) Outcomes of initial-onset acute uveitis associated with Vogt–Koyanagi–Harada disease occurred during pregnancy. International Ophthalmology 43:1, pages 185-195.
Crossref
Carsten Framme, Bernd Junker, Nicolas Feltgen, Hans Hoerauf, Nina-Antonia Striebe, Joachim Wachtlin & Ingo Volkmann. (2022) Indikationen zur intravitrealen Injektionstherapie mit Anti-VEGF für Makulaerkrankungen – Fehler vermeidenAvoiding mistakes in anti-VEGF intravitreal injection therapy. Der Ophthalmologe 119:3, pages 309-326.
Crossref
Shizhao Yang, Tianyu Tao, Zhaohao Huang, Xiuxing Liu, He Li, Lihui Xie, Feng Wen, Wei Chi & Wenru Su. (2022) Adalimumab in Vogt-Koyanagi-Harada Disease Refractory to Conventional Therapy. Frontiers in Medicine 8.
Crossref
PradeepKumar Panigrahi. (2022) A rare case of Vogt–Koyanagi–Harada disease presenting simultaneously with pituitary macroadenoma. Kerala Journal of Ophthalmology 34:1, pages 65.
Crossref
Carl P. HerbortJrJr, Ilknur Tugal-Tutkun, Ahmed Abu-El-Asrar, Amod Gupta, Masaru Takeuchi, Christine Fardeau, Alireza Hedayatfar, Cristhian Urzua & Ioannis Papasavvas. (2021) Precise, simplified diagnostic criteria and optimised management of initial-onset Vogt–Koyanagi–Harada disease: an updated review. Eye 36:1, pages 29-43.
Crossref
Alan D. Proia & Keith J. Wroblewski. 2022. Albert and Jakobiec's Principles and Practice of Ophthalmology. Albert and Jakobiec's Principles and Practice of Ophthalmology
6131
6221
.
Meng Feng, Shuping Zhou, Tong Liu, Yong Yu, Qinghong Su, Xiaofan Li, Min Zhang, Xiao Xie, Tingting Liu & Wei Lin. (2021) Association Between Interleukin 35 Gene Single Nucleotide Polymorphisms and the Uveitis Immune Status in a Chinese Han Population. Frontiers in Immunology 12.
Crossref
Anila Hussain & Ritu Khurana. (2021) Vogt-Koyanagi-Harada Syndrome: A Diagnostic Conundrum. Cureus.
Crossref
Ahmed M. Abu El‐Asrar, Waleed Alsarhani, Abdullah Alzubaidi & Priscilla W. Gikandi. (2021) Effect of immunosuppressive therapy on ocular blood flow in initial‐onset acute uveitis associated with Vogt–Koyanagi–Harada disease. Acta Ophthalmologica 99:8.
Crossref
Abdulrahman F. AlBloushi, Carl P. HerbortJr.Jr. & Ahmed M. Abu El-Asrar. (2021) Initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease presenting with unilateral exudative retinal detachment despite bilateral choroidal involvement. International Ophthalmology 41:12, pages 4187-4195.
Crossref
Ahmed M. Abu El-Asrar, Jo Van Damme, Sofie Struyf & Ghislain Opdenakker. (2021) New Perspectives on the Immunopathogenesis and Treatment of Uveitis Associated With Vogt-Koyanagi-Harada Disease. Frontiers in Medicine 8.
Crossref
Xiaoyuan Ye, Haiping Zhang, Peng Xiao, Gengyuan Wang, Xiaoqing Hu, Chun Yan, Fan Li, Yixin Hu, Lishi Su, Jiawen Luo, Jin Yuan, Feng Wen & Wei Chi. (2021) Microvasculature Features of Vogt-Koyanagi-Harada Disease Revealed by Widefield Swept-Source Optical Coherence Tomography Angiography. Frontiers in Medicine 8.
Crossref
Marketa Kaucka, Bara Szarowska, Michaela Kavkova, Maria Eleni Kastriti, Polina Kameneva, Inga Schmidt, Lucie Peskova, Alberto Joven Araus, Andras Simon, Jozef Kaiser & Igor Adameyko. (2021) Nerve-associated Schwann cell precursors contribute extracutaneous melanocytes to the heart, inner ear, supraorbital locations and brain meninges. Cellular and Molecular Life Sciences 78:16, pages 6033-6049.
Crossref
Ahmed M. Abu El‐Asrar, Mohammed D. Alotaibi, Priscilla W. Gikandi & Einar Stefánsson. (2020) Effect of immunosuppressive therapy on oxygen saturation and diameter of retinal vessels in initial onset acute uveitis associated with Vogt‐Koyanagi‐Harada disease. Acta Ophthalmologica 99:1, pages 75-82.
Crossref
Peizeng YangPeizeng Yang. 2021. Atlas of Uveitis. Atlas of Uveitis
411
537
.
Horst Helbig & Carl Herbort. 2021. Entzündliche Augenerkrankungen. Entzündliche Augenerkrankungen
685
699
.
Quan Zhang, Xing Fan, Meng Tian & Hongling Han. (2020) A case presentation of an IgA nephropathy patient with Vogt-Koyanagi-Harada syndrome. BMC Nephrology 21:1.
Crossref
Sowkath Ali, Hnin Hnin Oo, Rupesh Agarwal & Peh Khaik Khee. (2020) Concurrent presence of retinal hemorrhages in the setting of acute Vogt-Koyanagi-Harada syndrome - an unusual presentation. Journal of Ophthalmic Inflammation and Infection 10:1.
Crossref
Alia M. Albalawi & Maan A. Al-Barry. (2020) Genetic variations in autoimmune genes and VKH disease. International Ophthalmology 40:11, pages 3175-3186.
Crossref
Andreas Reiff. (2020) Clinical Presentation, Management, and Long‐Term Outcome of Pars Planitis, Panuveitis, and Vogt‐Koyanagi‐Harada Disease in Children and Adolescents. Arthritis Care & Research 72:11, pages 1589-1596.
Crossref
Carl P. HerbortJr.Jr., Ilknur Tugal-Tutkun, Moncef Khairallah, Ahmed M. Abu el Asrar, Carlos E. Pavésio & Masoud Soheilian. (2020) Vogt–Koyanagi–Harada disease: recurrence rates after initial-onset disease differ according to treatment modality and geographic area. International Ophthalmology 40:9, pages 2423-2433.
Crossref
Luca Cimino. 2020. The Uveitis Atlas. The Uveitis Atlas
79
100
.
Alan D. Proia & Keith J. Wroblewski. 2020. Albert and Jakobiec's Principles and Practice of Ophthalmology. Albert and Jakobiec's Principles and Practice of Ophthalmology
1
92
.
Carl P. HerbortJr.Jr., Ahmed M. Abu El Asrar, Masuru Takeuchi, Carlos E. Pavésio, Cristobal Couto, Alireza Hedayatfar, Kazuichi Maruyama, Xi Rao, Sukhum Silpa-archa & Thanapong Somkijrungroj. (2018) Catching the therapeutic window of opportunity in early initial-onset Vogt–Koyanagi–Harada uveitis can cure the disease. International Ophthalmology 39:6, pages 1419-1425.
Crossref
Thanh-Thao Adriana Le, Sumu Simon, Jagjit Gilhotra & Pravin Hissaria. (2019) Vogt-Koyanagi-Harada syndrome presenting with bilateral optic disc swelling and leptomeningeal enhancement. BMJ Case Reports 12:5, pages e229719.
Crossref
Nadiya B. Kuryltsiv & Kateryna M. Halei. (2019) THE ROLE OF INTERLEUKINS AND THEIR INHIBITORS IN THE DEVELOPMENT OF AUTOIMMUNE UVEITIS. Wiadomości Lekarskie 72:4, pages 716-722.
Crossref
Chan Zhao, Fangtian Dong, Fei Gao, Xinshu Liu, Minghang Pei, Shanshan Jia & Meifen Zhang. (2018) Longitudinal observation of subretinal fibrosis in Vogt-Koyanagi-Harada disease. BMC Ophthalmology 18:1.
Crossref
Guo Huang, Junchao Peng, Zi Ye, Aize Kijlstra, Donglei Zhang & Peizeng Yang. (2017) Multispectral image analysis in Vogt–Koyanagi–Harada disease. Acta Ophthalmologica 96:4, pages 411-419.
Crossref
Kanika Aggarwal, Aniruddha Agarwal, Ankit Deokar, Sarakshi Mahajan, Ramandeep Singh, Reema Bansal, Aman Sharma, Mangat R. Dogra & Vishali Gupta. (2017) Distinguishing features of acute Vogt-Koyanagi-Harada disease and acute central serous chorioretinopathy on optical coherence tomography angiography and en face optical coherence tomography imaging. Journal of Ophthalmic Inflammation and Infection 7:1.
Crossref
Carl P. Herbort Jr, Ahmed M. Abu El Asrar, Joyce H. Yamamoto, Carlos E. Pavésio, Vishali Gupta, Moncef Khairallah, Ilknur Tugal-Tutkun, Masoud Soheilian, Masuru Takeuchi & Marina Papadia. (2016) Reappraisal of the management of Vogt–Koyanagi–Harada disease: sunset glow fundus is no more a fatality. International Ophthalmology 37:6, pages 1383-1395.
Crossref
Ravindra Kumar Garg, Hardeep Singh Malhotra, Neeraj Kumar & Ravi Uniyal. (2017) Vision loss in tuberculous meningitis. Journal of the Neurological Sciences 375, pages 27-34.
Crossref
Ahmed M. Abu El‐Asrar, Mona Dosari, Suhail Hemachandran, Priscilla W. Gikandi & Abdulrahman Al‐Muammar. (2016) Mycophenolate mofetil combined with systemic corticosteroids prevents progression to chronic recurrent inflammation and development of ‘sunset glow fundus’ in initial‐onset acute uveitis associated with Vogt–Koyanagi–Harada disease. Acta Ophthalmologica 95:1, pages 85-90.
Crossref
Jillian M. Richmond & John E. Harris. 2017. Clinical and Basic Immunodermatology. Clinical and Basic Immunodermatology
511
525
.
Bo Li, Ricarda J. Bentham & John R. Gonder. (2016) A case of unilateral and spontaneously resolving posterior uveitis with overlapping features of Vogt–Koyanagi–Harada disease and Acute Posterior Multifocal Placoid Pigment Epitheliopathy. SpringerPlus 5:1.
Crossref
Mei Li, Qiuhui Liu, Yan Luo, Yonghao Li, Shaofen Lin, Ping Lian, Qiufen Yang, Xiaofang Li, Xialin Liu, SriniVas Sadda & Lin Lu. (2016) Enhanced Depth SD-OCT Images Reveal Characteristic Choroidal Changes in Patients With Vogt-Koyanagi-Harada Disease. Ophthalmic Surgery, Lasers and Imaging Retina 47:11, pages 1004-1012.
Crossref
Marwan A. Abouammoh, Vishali Gupta, Suhail Hemachandran, Carl P. Herbort & Ahmed M. Abu El‐Asrar. (2016) Indocyanine green angiographic findings in initial‐onset acute Vogt–Koyanagi–Harada disease. Acta Ophthalmologica 94:6, pages 573-578.
Crossref
Sukhum Silpa-archa, Narumol Silpa-archa, Janine M. Preble & C. Stephen Foster. (2016) Vogt–Koyanagi–Harada syndrome: Perspectives for immunogenetics, multimodal imaging, and therapeutic options. Autoimmunity Reviews 15:8, pages 809-819.
Crossref
Sky K. Chew, Jaime Levy, Sophie Rogers & Lyndell L. Lim. (2016) Long-term Outcomes of Limited Vogt-Koyanagi-Harada Syndrome. American Journal of Ophthalmology 167, pages 52-56.
Crossref
Faisal A. Almobarak, Ali H. Alharbi, Jose Morales & Ibrahim Aljadaan. (2016) Outcomes of Trabeculectomy With Mitomycin-C in Uveitis Associated With Vogt-Koyanagi-Harada Disease. Journal of Glaucoma 25:6, pages 528-532.
Crossref
Liping Du, Aize Kijlstra & Peizeng Yang. (2016) Vogt-Koyanagi-Harada disease: Novel insights into pathophysiology, diagnosis and treatment. Progress in Retinal and Eye Research 52, pages 84-111.
Crossref
Luca Cimino. 2016. The Uveitis Atlas. The Uveitis Atlas
1
23
.
Khaled Ezzedine, Vaneeta Sheth, Michelle Rodrigues, Viktoria Eleftheriadou, John E. Harris, Iltefat H. Hamzavi & Amit G. Pandya. (2015) Vitiligo is not a cosmetic disease. Journal of the American Academy of Dermatology 73:5, pages 883-885.
Crossref
K. Wand, S. Abraham, D. Loos, S. Stumpfe, C. Lohmann, M. Maier & N. Feucht. (2015) Langzeitverlauf unter immunsuppressiver Therapie bei Vogt-Koyanagi-Harada-SyndromLong-term course of immunosuppressive therapy of Vogt-Koyanagi-Harada syndrome. Der Ophthalmologe 112:10, pages 857-860.
Crossref
Dusheng Lin, Weiqi Chen, Guihua Zhang, Huichun Huang, Zhaotao Zhou, Lingping Cen & Haoyu Chen. (2014) Comparison of the optical coherence tomographic characters between acute Vogt-Koyanagi-Harada disease and acute central serous chorioretinopathy. BMC Ophthalmology 14:1.
Crossref
Yanyun Shi, Yading Jia, Shengping Hou, Jing Fang, Yan Zhou, Aize Kijlstra & Peizeng Yang. (2014) Association of a TNIP1 Polymorphism with Vogt-Koyanagi-Harada Syndrome but Not with Ocular Behcet’s Disease in Han Chinese. PLoS ONE 9:5, pages e95573.
Crossref
René Robles-Cedeño, Joan Felip Fures, Albert Molins, Lara Martin Muñoz & Lluís Ramió-Torrentà. (2013) A Moroccan patient with Vogt–Koyanagi–Harada syndrome and bilateral Adie’s pupils. Neurological Sciences 35:3, pages 483-485.
Crossref
Rengarajan R. 2005. Radiopaedia.org. Radiopaedia.org.
Qin Xiang, Lu Chen, Shengping Hou, Jing Fang, Yan Zhou, Lin Bai, Yunjia Liu, Aize Kijlstra & Peizeng Yang. (2014) TRAF5 and TRAF3IP2 Gene Polymorphisms Are Associated with Behçet's Disease and Vogt-Koyanagi-Harada Syndrome: A Case-Control Study. PLoS ONE 9:1, pages e84214.
Crossref
Özlem Bilgiç, Abuzer Gündüz & Kısmet Kaya. (2013) Vogt‐Koyanagi‐Harada Disease in an Adolescent Boy. Pediatric Dermatology 31:1, pages 99-101.
Crossref
S. E. Coupland, Christoph Deuter, Enken Gundlach, Horst Helbig, Carl Herbort, Florian Heußen, Tobias Hudde, Doris Jähne, Pascal B. Knecht, Thomas Neß, Bernhard Nölle, Marina Papadia, Uwe Pleyer, Agnes B. Renner, Torsten Schlote, Nicole Stübiger, Stephan Thurau, Sibylle Winterhalter, Teresa Barth & Manfred Zierhut. 2014. Entzündliche Augenerkrankungen. Entzündliche Augenerkrankungen
395
516
.
Fiona Roberts & Chee Koon ThumFiona Roberts & Chee Koon Thum. 2014. Lee's Ophthalmic Histopathology. Lee's Ophthalmic Histopathology
177
206
.
Andreas Reiff, Sibel Kadayifcilar & Seza Özen. (2013) Rheumatic Inflammatory Eye Diseases of Childhood. Rheumatic Disease Clinics of North America 39:4, pages 801-832.
Crossref
Ahmed M. Abu El-Asrar, Mamdouh Al Tamimi, Suhail Hemachandran, Hani S. Al-Mezaine, Abdulrahman Al-Muammar & Dustan Kangave. (2013) Prognostic factors for clinical outcomes in patients with Vogt-Koyanagi-Harada disease treated with high-dose corticosteroids. Acta Ophthalmologica 91:6, pages e486-e493.
Crossref
Shaojuan GuYu LiuZhi SongXiaohong ZiHao Deng. (2013) Acute Myelitis in a Patient with Vogt-Koyanagi-Harada Disease: Case Report and Review of the Literature. Journal of Clinical Neurology 9:1, pages 61.
Crossref
Maria de Lourdes Arellanes-García, Luz Elena Concha-del-Río, Maria del Carmen Preciado-Delgadillo & Claudia Recillas-Gipsert. 2013. Retinal and Choroidal Manifestations of Selected Systemic Diseases. Retinal and Choroidal Manifestations of Selected Systemic Diseases
353
376
.
Ahmed M. Abu El‐Asrar, Suhail Hemachandran, Hani S. Al‐Mezaine, Dustan Kangave & Abdulrahman M. Al‐Muammar. (2012) The outcomes of mycophenolate mofetil therapy combined with systemic corticosteroids in acute uveitis associated with Vogt–Koyanagi–Harada disease. Acta Ophthalmologica 90:8.
Crossref
Claudia Hernandez, Caroline LePoole & Howard H. Tessler. (2011)
Vogt–Koyanagi–Harada Syndrome in a 6‐Year‐Old Hispanic Boy
1
. Pediatric Dermatology 29:2, pages 191-194.
Crossref
Klara Landau & Malaika Kurz-levin. 2011. Neuro-ophthalmology. Neuro-ophthalmology
97
116
.
B. Bourre, J. Aupy, M. Saleh, D. Gaucher, L. Thomas, C. Tranchant, J. De Seze & N. Collongues. (2010) Atteinte audiovisuelle inaugurale de pathologies neurologiques spécifiques. Revue Neurologique 166:12, pages 1017-1023.
Crossref
Jonathan Lipps & Muhammad Asim Khan. (2010) Vogt–Koyanagi–Harada syndrome: a rheumatologic perspective. International Journal of Clinical Rheumatology 5:2, pages 255-263.
Crossref
Ralph D. Levinson, Annabelle A. Okada, Elham Ashouri, Hiroshi Keino & Raja Rajalingam. (2010) Killer cell immunoglobulin-like receptor gene-cluster 3DS1-2DL5-2DS1-2DS5 predisposes susceptibility to Vogt–Koyanagi–Harada syndrome in Japanese individuals. Human Immunology 71:2, pages 192-194.
Crossref
R. Jouenne, Ch. Pagnoux & L. Guillevin. 2010. Les Uvéites. Les Uvéites
645
660
.
Robert B. Nussenblatt. 2010. Uveitis. Uveitis
303
318
.
S. Thurau & G. Wildner. (2010) ChorioiditisChoroiditis. Der Ophthalmologe 107:1, pages 79-93.
Crossref
Laura A. JohnsonRichard A. MorganMark E. DudleyLydie CassardJames C. YangMarybeth S. HughesUdai S. KammulaRichard E. RoyalRichard M. SherryJohn R. WunderlichChyi-Chia R. LeeNicholas P. RestifoSusan L. SchwarzAlexandria P. CogdillRachel J. Bishop, Hung Kim, Carmen C. Brewer, Susan F. Rudy, Carter VanWaes, Jeremy L. DavisAarti MathurRobert T. RipleyDebbie A. NathanCarolyn M. LaurencotSteven A. Rosenberg. (2009) Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen. Blood 114:3, pages 535-546.
Crossref
Patrick Oellers & Gary C. Brown. (2009) PROGNOSTIC FACTORS OF VOGT-KOYANAGI-HARADA DISEASE IN SINGAPORE. Evidence-Based Ophthalmology 10:3, pages 154-155.
Crossref
K. J. SCHMIDT, K. FELLERMANN, P. WELLHÖNER, G. WEITZ, N. HOMANN, K. HERRLINGER, H. LEHNERT, D. LUDWIG & J. BÜNING. (2009) Clinical trial: cyclophosphamide pulse therapy – a promising therapeutic alternative in refractory Crohn’s disease. Alimentary Pharmacology & Therapeutics 29:12, pages 1230-1239.
Crossref
Micheal J. Gallagher, Taygan Yilmaz & C. Stephen Foster. (2009) Vogt-Koyanagi-Harada Syndrome Associated With Bilateral Serous Macular Detachments Responsive to Immunomodulatory Therapy. Ophthalmic Surgery, Lasers and Imaging Retina 40:3, pages 345-347.
Crossref
Hee Kyung YangHyeong Gon Yu. (2009) Acute Lymphoblastic Leukemia Manifesting as Acute Vogt-Koyanagi-Harada Disease. Korean Journal of Ophthalmology 23:4, pages 325.
Crossref